HB1206--INDIVIDUALIZED INVESTIGATIONAL TREATMENT
SPONSOR: Stinnett
Thisbillestablishesthe"HopeforMissouriPatientsAct",which
permitseligiblemanufacturerswithineligiblefacilitiestomake
availableindividualized investigational drugs,biological
products,ordevicesforeligiblepatients,butdoesnotmandate
theprovisionofthesedrugs,products,ordevicestopatients.
Thebillallowsfacilitiesormanufacturerstoeitherprovidethese
itemstopatientswithoutreceivingcompensationortorequirea
patienttopaythecostsofthemanufactureofthesedrugs,
products,ordevices. Thebilladditionallypermits,butdoesnot
require,healthplans,third-partyadministrators, orgovernmental
agenciestoprovidecoverageforthecostsoforassociatedwith
thesedrugs,products,ordevices,andprovidesthathospitalsor
facilitieslicensedbytheDepartmentandHealthandSenior
Servicestoprovideneworadditionalservicesunlessapprovedby
thehospitalorfacility.
Ifapatient'sdeathisproximatelycausedbytreatmentwiththese
drugs,products,ordevices,thepatient'sestate,heirs,or
deviseesarenotliableforanyremainingdebt,butthisisnot
construedtobeanexemptiontoliabilityforanychargesfornon-
experimentaltreatmentsprovidedtothepatient.
Nolicensingboardordisciplinarysubcommitteeistorevoke,fail
torenew,suspend,ortakeanyactionagainstahealthcare
provider'slicensebasedsolelyontheprovider'srecommendations
toaneligiblepatientregardingaccessto,ortreatmentwith,
thesedrugs,products,ordevices,norwillanentityresponsible
forMedicarecertificationdothesameforaprovider'sMedicare
certification.
Thebilladditionallyprohibitsanystateofficial,employee,or
agentfromblockingorattemptingtoblockapatient'saccessto
thesedrugs,products,ordevices;providesthatcounselingfroma
licensedhealthcareproviderconsistentwithmedicalstandardsof
careisnotaviolationofthisbill;andthataprivatecauseof
actionagainstamanufacturerofthesedrugs,products,ordevices
isnotestablishedthroughtheprovisionsofthisbill.